Toggle navigation
Home
Search
Services
Blog
Contact
About
A Rapid Acting Lorazepam Gel for Epileptic Seizures
Nuwayser, Es S.
Biotek, Inc., Woburn, MA, United States
Search 7 grants from Es Nuwayser
Search grants from Biotek, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
Pharmacokinetic and Programmatic Evaluations to Optimize HIV/TB Co-Treatment Regimens in Children
Imaging Transgene Expression in Gene Therapy Protocols
NMDA Receptor - Agonist Affinity, Efficacy/Transduction
Molecular Mechanisms Whereby Ctg Expansion Results in Dm
Recently added grants:
Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)
ENHANCE: Developing a Clinical Geography Tool to Intervene in Cognitive Decline through Neighborhood Design
How does dividing attention limit object recognition and modify relevant neural activity?
Identifying genetic code reassignments in nucleotide sequence databases
Role of Perivascular Stem Cells in Ligament Healing and Regeneration
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43NS082389-001
Application #
6011548
Study Section
Project Start
1998-07-01
Project End
1999-01-29
Budget Start
1998-12-11
Budget End
1999-01-29
Support Year
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Biotek, Inc.
Department
Type
DUNS #
City
Woburn
State
MA
Country
United States
Zip Code
01801
Related projects
NIH 1999
N43 NS
A Rapid Acting Lorazepam Gel for Epileptic Seizures
Nuwayser, Es S. / Biotek, Inc.
NIH 1998
N43 NS
A Rapid Acting Lorazepam Gel for Epileptic Seizures
Nuwayser, Es S. / Biotek, Inc.
Comments
Be the first to comment on Es Nuwayser's grant